Trevogrumab 1mg
Price range: $194.95 through $1,940.00
Trevogrumab 1mg is a human monoclonal antibody specifically designed for the neutralization of myostatin, a key player in muscle mass regulation. Ideal for research applications, this peptide provides a pathway to explore muscle growth and development.
Overview
Trevogrumab (REGN1033, SAR-391786) is an innovative research peptide that targets myostatin, also known as GDF-8. Myostatin is a member of the TGF-beta superfamily and serves as a crucial negative regulator of skeletal muscle mass. By neutralizing myostatin, Trevogrumab allows researchers to comprehensively investigate muscle growth dynamics, giving insights into potential therapies for muscle wasting conditions.
Key Features
- Fully human monoclonal antibody
- High-affinity selective neutralization of myostatin
- Specific to myostatin with no cross-reactivity to other ligands
- Stable at room temperature for several days to weeks
- Ideal for myostatin pathway antagonist research
Specifications
| Product Name | Trevogrumab |
| Concentration | 1 mg |
| Form | Liquid |
| Storage | Room temperature |
FAQ
What is Trevogrumab used for?
Trevogrumab is primarily used in research settings to study the effects of myostatin inhibition on muscle growth and development.
How should I store Trevogrumab?
This peptide is stable at room temperature and can be stored in its original packaging for several days to weeks, making it convenient for researchers.
Is there any cross-reactivity with other ligands?
No, Trevogrumab is designed specifically to neutralize myostatin without affecting other ActRIIB-binding ligands.
For those exploring the potential of muscle growth and therapeutic applications, Trevogrumab 1mg is available for purchase. Experience the benefits of our peptides and elevate your research today. Don’t miss out on this opportunity to enhance your projects with top-tier research materials.
Related Products
Browse more in NEW!.
| Trevogrumab 1mg | 1 vial, KIT (10 vials) |
|---|
Related products
